Please assess the completion status of the following clinical trial:

Trial Title: Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* healthy volunteers~* age above 18~Exclusion Criteria:~* any chronic disease~* any drug intake

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Treprostinil (Type: EXPERIMENTAL): Treprostinil iontophoresis (250, 25 and 2.5 microM)
- Iloprost (Type: EXPERIMENTAL): Iloprost iontophoresis (200, 20 and 2 microM)
- NaCl 0.9% (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).